Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Cavallieri

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Journal of Neurology|March 4, 2024
Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registryMaurizio Angelo Leone, Raimund Helbok, Elisa Bianchi, et al.
European Journal of Neurology|March 27, 2023
Interplay between speech and gait variables in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: A long-term instrumental assessmentFrancesco Cavallieri, Annalisa Gessani, Andrea Merlo, et al.
Journal of Neurology|May 19, 2023
Long-term effects of bilateral subthalamic nucleus deep brain stimulation on gait disorders in Parkinson's disease: a clinical-instrumental studyFrancesco Cavallieri, Isabella Campanini, Annalisa Gessani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 25, 2023
Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohortMicol Avenali, Roberta Zangaglia, Giada Cuconato, et al.
Movement Disorders Clinical Practice|September 9, 2025
Artificial Intelligence Predicts GBA1 Mutated Status in Parkinson's Disease PatientsGiulia Di Rauso, Alessandro Ghibellini, Sara Grisanti, et al.
Nature Medicine|April 20, 2026
Microbiome signature of Parkinson's disease in healthy and genetically at-risk individualsElisa Menozzi, Yani Ren, Mallia Geiger, et al.
European Journal of Neurology|February 23, 2022
Short- and long-term outcome and predictors in an international cohort of patients with neuro-COVID-19Ettore Beghi, Raimund Helbok, Serefnur Ozturk, et al.
Parkinsonism & Related Disorders|June 6, 2024
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's diseaseMassimo Marano, Carmela Zizzo, Maria Chiara Malaguti, et al.
NPJ Parkinson'S Disease|October 17, 2025
Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulationFrancesco Bove, Danilo Genovese, Alessandro De Biase, et al.
Movement Disorders Clinical Practice|September 13, 2024
Family History in Parkinson's Disease: A National Cross-Sectional StudyFederica Arienti, Giovanni Casazza, Giulia Franco, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Journal of Neurology|March 4, 2024
Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registryMaurizio Angelo Leone, Raimund Helbok, Elisa Bianchi, et al.
European Journal of Neurology|March 27, 2023
Interplay between speech and gait variables in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: A long-term instrumental assessmentFrancesco Cavallieri, Annalisa Gessani, Andrea Merlo, et al.
Journal of Neurology|May 19, 2023
Long-term effects of bilateral subthalamic nucleus deep brain stimulation on gait disorders in Parkinson's disease: a clinical-instrumental studyFrancesco Cavallieri, Isabella Campanini, Annalisa Gessani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 25, 2023
Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohortMicol Avenali, Roberta Zangaglia, Giada Cuconato, et al.
Movement Disorders Clinical Practice|September 9, 2025
Artificial Intelligence Predicts GBA1 Mutated Status in Parkinson's Disease PatientsGiulia Di Rauso, Alessandro Ghibellini, Sara Grisanti, et al.
Nature Medicine|April 20, 2026
Microbiome signature of Parkinson's disease in healthy and genetically at-risk individualsElisa Menozzi, Yani Ren, Mallia Geiger, et al.
European Journal of Neurology|February 23, 2022
Short- and long-term outcome and predictors in an international cohort of patients with neuro-COVID-19Ettore Beghi, Raimund Helbok, Serefnur Ozturk, et al.
Parkinsonism & Related Disorders|June 6, 2024
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's diseaseMassimo Marano, Carmela Zizzo, Maria Chiara Malaguti, et al.
NPJ Parkinson'S Disease|October 17, 2025
Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulationFrancesco Bove, Danilo Genovese, Alessandro De Biase, et al.
Movement Disorders Clinical Practice|September 13, 2024
Family History in Parkinson's Disease: A National Cross-Sectional StudyFederica Arienti, Giovanni Casazza, Giulia Franco, et al.
Pageof 11